Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2025-12-25 @ 3:30 AM
NCT ID:
NCT04517305
Eligibility Criteria:
Inclusion Criteria:
* woman, age \> 18 years old
* diagnosed with HER2 +Metastatic Breast Cancer
* pyrotinib plus vinorelbine for at least one cycle, starting from 2018.05-2020.05
* available medical history
Exclusion Criteria:
* medical history was incomplete
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT04517305
Study Brief:
Protocol Section:
NCT04517305